Table 4.
Antibiogram of Enterobacteriace.
| Antibiotics | Escherichia coli (n = 17) | Klebsiella species (n = 13) | Citrobacter species (n = 11) | Proteus species (n = 10) | Total (n = 51) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| S (%) | R (%) | S (%) | R (%) | S (%) | R (%) | S (%) | R (%) | S (%) | R (%) | |
| Amikacin | 13 (76.5%) | 4 (23.5%) | 9 (69.2%) | 4 (30.8%) | 5 (45.4%) | 6 (54.5%) | 3 (30%) | 7 (70%) | 30 (58.8%) | 21 (41.2%) |
| Cefoperazone | 3 (17.6%) | 14 (82.35%) | 4 (30.8%) | 9 (69.2%) | 2 (18.2%) | 9 (81.8%) | 3 (30%) | 7 (70%) | 15 (29.4%) | 22 (43.1%) |
| Cefixime | 6 (35.3%) | 11 (64.7%) | 2 (15.4%) | 11 (84.6%) | 10 (90.9%) | 1 (9.0%) | 6 (60%) | 4 (40%) | 24 (47.0%) | 27 (52.9%) |
| Cefepime | 6 (35.3%) | 11 (64.7%) | 10 (76.9%) | 3 (23.1%) | 4 (36.4%) | 7 (63.6%) | 5 (50%) | 5 (50%) | 25 (49.0%) | 26 (51.0%) |
| Cefetriaxone | 6 (35.3%) | 11 (64.7%) | 10 (76.9%) | 3 (23.1%) | 2 (18.2%) | 9 (81.8%) | 4 (40%) | 6 (60%) | 22 (43.1%) | 29 (56.9%) |
| Gentamicin | 5 (29.4%) | 12 (70.6%) | 6 (46.15%) | 7 (53.8%) | 4 (36.4%) | 7 (63.6%) | 4 (40%) | 6 (60%) | 19 (37.2%) | 32 (62.7%) |
| Levofloxacin | 5 (29.4%) | 12 (70.6%) | 10 (76.9%) | 3 (23.1%) | 6 (54.5%) | 5 (45.4%) | 4 (40%) | 6 (60%) | 25 (49.0%) | 26 (51.0%) |
| Tobramycin | 5 (29.4%) | 12 (70.6%) | 6 (46.15%) | 7 (53.8%) | 6 (54.5%) | 5 (45.4%) | 3 (30%) | 7 (70%) | 20 (39.2%) | 30 (58.8%) |
| Cefeperazone + Sulbactam | 8 (47.0%) | 9 (52.9%) | 12 (92.3%) | 1 (7.7%) | 5 (45.4%) | 6 (54.5%) | 6 (60%) | 4 (40%) | 31 (60.8%) | 20 (39.2%) |
S, sensitive; R, resistant; n, number of isolates.